• Work with us
  • External Contractors
Fondazione Toscana Life Sciences
  • IT
  • EN
Toscana Life Sciences
  • THE FOUNDATION
    • Organization
    • History
    • Membership
    • The Legislative Decree No. 231/2001
  • Activity
  • Cluster
  • ITS VITA
  • BIOINCUBATOR
    • Join the Bioincubator
    • Incubated companies
    • Research groups
    • Affiliated companies
  • Services
    • Business development services
    • Research services
    • Incubation services
    • Protection of intellectual property
  • Projects
    • ERC Advanced Grant OMVac
    • Monoclonal Antibody Discovery (MAD) LAB
    • ERC Advanced Grant VACCIBIOME
    • My First AIRC grant @Tumour Immunology Unit
    • Regions4PerMed
    • COSME-AI4DIAG
    • IDF SHARID
    • BORNTOGEtTHERe
    • SINO-EU‐PERMED
    • Orphan diseases
  • Disseminating
    • TLS Open Doors
    • Scientists for a day
    • Science + Economy = Business
    • Researcher’s Night
    • European Biotech Week
  • TLS4Covid19
  • Stories
Enter any keyword and press enter

Center for Immuno-Oncology, University Hospital of Siena

  • BIOINCUBATOR
    • Join the Bioincubator
    • Incubated companies
    • Research groups
    • Affiliated companies

Center for Immuno-Oncology, University Hospital of Siena



The Center for Immuno-Oncology (CIO) is a multidisciplinary entity of the Azienda Ospedaliera Universitaria Senese (AOUS), established in 2017 by the AOUS to allow clinical and pre-clinical researchers to operate in a highly integrated, comprehensive scientific environment dedicated to cancer immunotherapy.

The CIO has 4 fundamental structural units: the clinical facilities of Medical Oncology and Immunotherapy, the Clinical Research unit for clinical trials, the Translational Laboratories dedicated to the activities supporting the clinical trial programs, and the Pre-Clinical Laboratories dedicated to basic research (located at MRC).

Main activities of the Center are:
- Clinical and experimental immunotherapy of solid malignancies.
- Immunomonitoring of patients treated within clinical trials of cancer immunotherapy.
- Epigenetic regulation of immune-related mechanisms involved in tumor progression and resistance to immunotherapy.
- Immunomodulatory activity of new epigenetic drugs to identify new partners for immunotherapy protocols.
- Therapeutic efficacy of new bio-immunotherapeutic agents and their combinations to evaluate their anti-tumor activities.


ao-siena.toscana.it

Fondazione Toscana Life Sciences
Via Fiorentina, 1
53100 Siena – ITALIA

  • tel +39 0577 231211
  • fax +39 0577 43444
  • info@toscanalifesciences.org; info@pec.fondazionetls.org

Twitter Feeds

La ricerca scientifica 👩‍🔬si rafforza anche grazie al nuovo accordo sottoscritta dalla Fondazione Volterra Ricerche…

@FondazioneTLS 12 Hours Ago

📍Tappa senese per Foulard d’Autore, una carezza di solidarietà, di @ReginaSchrecker. 👉La stilista di fama interna…

@FondazioneTLS 2 Days Ago

Toscana Life Sciences aderisce a RetImpresa, Agenzia nazionale di @Confindustria per le aggregazioni e le reti di i…

@FondazioneTLS About a Week Ago

Contatti

    Concedo il consenso al trattamento dei dati personali secondo la nostra Privacy Policy per poter essere contattato da Fondazione Toscana Life Sciences.

©2015-2019 - Fondazione Toscana Life Sciences - P.I. 01194710529 - Codice SDI: SUBM70N - Privacy - Cookie Policy